HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosaria De Filippi Selected Research

Radioimmunotherapy

4/202290-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosaria De Filippi Research Topics

Disease

11Neoplasms (Cancer)
12/2021 - 10/2003
7Hodgkin Disease (Hodgkin's Disease)
12/2021 - 09/2009
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 01/2012
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2012 - 08/2006
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2022
1Residual Neoplasm
04/2022
1Overweight
12/2021
1COVID-19
06/2021
1Severe Acute Respiratory Syndrome
06/2021
1Infections
06/2021
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2021
1Disease Progression
06/2021
1Leukemia
02/2021
1Lymphoma (Lymphomas)
02/2021
1Meningitis
02/2021
1Primitive Neuroectodermal Tumors (PNET)
10/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2012
1T-Cell Lymphoma (Lymphoma, T Cell)
12/2011
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2011
1Carcinoma (Carcinomatosis)
08/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2009
1Lymphocytosis
09/2007
1Heart Failure
08/2006
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
08/2006
1Sepsis (Septicemia)
08/2006
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
08/2006

Drug/Important Bio-Agent (IBA)

4Rituximab (Mabthera)FDA Link
06/2021 - 08/2006
2LigandsIBA
12/2021 - 08/2011
2Biomarkers (Surrogate Marker)IBA
02/2021 - 01/2019
2Cytarabine (Cytosar-U)FDA LinkGeneric
02/2021 - 01/2012
2Biological ProductsIBA
01/2019 - 12/2011
2Doxorubicin (Adriamycin)FDA LinkGeneric
07/2014 - 09/2011
2Lenalidomide (CC 5013)FDA Link
03/2012 - 01/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2011 - 10/2003
1NivolumabIBA
12/2021
1Immune Checkpoint InhibitorsIBA
12/2021
1VaccinesIBA
07/2021
1AntibodiesIBA
06/2021
1Immunoglobulin G (IgG)IBA
06/2021
1Immunoglobulin M (IgM)IBA
06/2021
1RNA (Ribonucleic Acid)IBA
06/2021
1Viral RNAIBA
06/2021
1Arabinofuranosylcytosine TriphosphateIBA
02/2021
1pyrimidineIBA
02/2021
1NucleosidesIBA
02/2021
1EnzymesIBA
02/2021
1Pharmaceutical PreparationsIBA
01/2019
1AntigensIBA
12/2016
1Peptides (Polypeptides)IBA
12/2016
1Dacarbazine (DIC)FDA LinkGeneric
07/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
07/2014
1Vinblastine (Vinblastine Sulfate)FDA Link
07/2014
1Bendamustine HydrochlorideFDA Link
01/2013
1fotemustine (Muphoran)IBA
12/2011
1Vincristine (Oncovin)FDA LinkGeneric
09/2011
1Liposomes (Liposome)IBA
09/2011
1Prednisone (Sone)FDA LinkGeneric
09/2011
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2011
1ErbB Receptors (EGF Receptor)IBA
08/2011
1Otx Transcription FactorsIBA
12/2009
1TNF Receptor-Associated Factor 1IBA
10/2009
1Interleukin-6 (Interleukin 6)IBA
09/2009
1Interleukin-7 (Interleukin 7)IBA
09/2009
1ChemokinesIBA
09/2009
1InterleukinsIBA
09/2009
1CytokinesIBA
09/2009
1Hemoglobins (Hemoglobin)IBA
09/2007
1TransferasesIBA
08/2006
1SteroidsIBA
08/2006
1Monoclonal AntibodiesIBA
08/2006

Therapy/Procedure

4Therapeutics
02/2021 - 08/2006
3Immunotherapy
12/2021 - 10/2003
2Drug Therapy (Chemotherapy)
02/2021 - 10/2003
2Radiotherapy
07/2014 - 10/2003
1Radioimmunotherapy
04/2022
1Aftercare (After-Treatment)
04/2022
1Stem Cell Transplantation
01/2013